Mark Allen is the founder of Elevian. Elevian has raised $61M in total funding. Latest round: Series A. Based in Boston, United States.
Mark Allen, MD, PhD, is the Co-founder and CEO of Elevian, a Boston-based biotechnology company. He is a medical doctor and entrepreneur who co-founded Elevian to commercialize therapies using recombinant growth differentiation factor GDF11, aiming to treat age-related diseases. Elevian is a Harvard spinout focused on curing aging through modulating the GDF11 signaling pathway.
Full founder directory · Investor directory · Company funding database · Fundraising library